{
    "medicine_id": "1b730e221dd8418a2bb58e9c5073cdb87fd997cd",
    "platform_id": "DB00106",
    "metadata": {
        "name": "Intron A 38 ug 1mL Kit",
        "composition": "38 ug 1mL Abarelix",
        "clinical_particulars": {
            "therapeutic_indications": "For palliative treatment of advanced prostate cancer",
            "contraindications": {
                "disease": "The maximum tolerated dose of abarelix has not been determined The maximum dose used in clinical studies was 150 mg There have been no reports of accidental overdose with abarelix",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Used in the palliative treatment of advanced prostate cancer Abarelix is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}